15.53
price up icon5.29%   0.78
pre-market  Vorhandelsmarkt:  15.53  
loading
Schlusskurs vom Vortag:
$14.75
Offen:
$15.34
24-Stunden-Volumen:
2.96M
Relative Volume:
1.58
Marktkapitalisierung:
$12.96B
Einnahmen:
$3.85B
Nettoeinkommen (Verlust:
$667.93M
KGV:
23.64
EPS:
0.657
Netto-Cashflow:
$142.30M
1W Leistung:
+5.29%
1M Leistung:
+11.97%
6M Leistung:
+7.33%
1J Leistung:
+11.68%
1-Tages-Spanne:
Value
$15.10
$15.71
1-Wochen-Bereich:
Value
$14.61
$15.71
52-Wochen-Spanne:
Value
$12.26
$16.89

Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile

Name
Firmenname
Dr Reddys Laboratories Ltd Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
27,048
Name
Twitter
@drreddys
Name
Nächster Verdiensttermin
2025-01-23
Name
Neueste SEC-Einreichungen
Name
RDY's Discussions on Twitter

Vergleichen Sie RDY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
RDY
Dr Reddys Laboratories Ltd Adr
15.53 12.27B 3.85B 667.93M 142.30M 0.657
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.12 50.98B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
168.61 74.41B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.93 4.03M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.99 46.23B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.25 20.10B 16.54B -1.64B 749.00M -1.45

Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-19 Herabstufung Nomura Buy → Neutral
2024-01-11 Herabstufung Jefferies Buy → Underperform
2023-08-29 Herabstufung HSBC Securities Buy → Hold
2023-05-18 Herabstufung Bernstein Outperform → Mkt Perform
2023-03-17 Hochstufung BofA Securities Neutral → Buy
2023-01-30 Eingeleitet JP Morgan Underweight
2022-11-14 Herabstufung Credit Suisse Neutral → Underperform
2022-01-03 Fortgesetzt BofA Securities Neutral
2021-07-27 Herabstufung Credit Suisse Outperform → Neutral
2021-02-02 Hochstufung Barclays Equal Weight → Overweight
2020-09-18 Hochstufung BofA Securities Neutral → Buy
2020-09-18 Hochstufung Investec Sell → Hold
2020-01-28 Herabstufung CLSA Buy → Outperform
2020-01-27 Herabstufung CLSA Buy → Outperform
2020-01-09 Hochstufung Citigroup Sell → Buy
2019-11-04 Herabstufung BofA/Merrill Buy → Neutral
2019-09-04 Hochstufung Credit Suisse Underperform → Outperform
2019-07-01 Hochstufung Macquarie Neutral → Outperform
2019-06-20 Eingeleitet Deutsche Bank Hold
2019-06-11 Eingeleitet Barclays Equal Weight
2019-05-20 Herabstufung Morgan Stanley Overweight → Equal-Weight
2019-02-19 Hochstufung CLSA Outperform → Buy
2019-01-17 Herabstufung Citigroup Neutral → Sell
2017-09-21 Hochstufung Morgan Stanley Equal-Weight → Overweight
2017-08-31 Hochstufung CLSA Underperform → Outperform
2017-07-28 Herabstufung CLSA Underperform → Sell
2016-07-27 Herabstufung HSBC Securities Hold → Reduce
2016-07-27 Herabstufung Jefferies Hold → Underperform
2016-02-10 Hochstufung Credit Agricole Underperform → Buy
2015-11-10 Herabstufung Citigroup Buy → Neutral
Alle ansehen

Dr Reddys Laboratories Ltd Adr Aktie (RDY) Neueste Nachrichten

pulisher
Jun 05, 2025

HSBC Upgrades Dr. Reddy’s Laboratories Limited (RDY) to Buy from Hold - Insider Monkey

Jun 05, 2025
pulisher
Jun 05, 2025

Dr. Reddy’s stock rises on biosimilar collaboration with Alvotech - Investing.com Australia

Jun 05, 2025
pulisher
Jun 05, 2025

Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab) - GlobeNewswire Inc.

Jun 05, 2025
pulisher
Jun 05, 2025

HSBC upgrades Dr. Reddy’s stock rating citing semaglutide prospects - Investing.com Australia

Jun 05, 2025
pulisher
Jun 03, 2025

LLY Stock Quote Price and Forecast - CNN

Jun 03, 2025
pulisher
May 27, 2025

Asian Equities Gain In US Markets' Positive Start - Finimize

May 27, 2025
pulisher
May 13, 2025

Indian ADRs Surge in US Markets as Wall Street soars after US-China trade talks - Moneycontrol

May 13, 2025
pulisher
May 12, 2025

Shares To Buy For Short-term: Analysts recommend 5 largecap, 2 midcap stocks; Britannia, Dr Reddy's, TCS on the list - Zee Business

May 12, 2025
pulisher
May 10, 2025

Asian Equities Climb Despite Weekly Losses - Finimize

May 10, 2025
pulisher
May 09, 2025

Dr. Reddy’s Earnings: Year-End Numbers Look Solid as Demand and Prescription Trends Remain Resilient - Morningstar

May 09, 2025
pulisher
May 09, 2025

Dr. Reddy’s Laboratories Grants Stock Options to Employees in May 2025 - TipRanks

May 09, 2025
pulisher
May 09, 2025

Insider’s View: Deciphering Six Flags Entertainment Corp (FUN)’s Financial Health Through Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Balance Sheet Breakdown: Astrazeneca plc ADR (AZN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Ratio Examination: Dr. Reddy’s Laboratories Ltd. ADR (RDY)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 09, 2025
pulisher
May 09, 2025

Metric Deep Dive: Understanding Phio Pharmaceuticals Corp (PHIO) Through its Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Financial Analysis: Spotify Technology S.A (SPOT)’s Ratios Unveil Key Insights - DWinneX

May 09, 2025
pulisher
May 09, 2025

5 Indian ADRs crash up to 14% amid rising India-Pakistan military conflict - Trade Brains

May 09, 2025
pulisher
May 08, 2025

Indian Markets Set for Bloody Friday as Gift Nifty Signals Sharp Gap-Down Open Amid Escalating India-Pak Tensions - outlookbusiness.com

May 08, 2025
pulisher
May 08, 2025

Indian ADRs slump as India-Pakistan conflict sees escalation - Moneycontrol

May 08, 2025
pulisher
May 08, 2025

Gift Nifty, India ADRs see sharp sell-off following escalation in India-Pakistan conflict - Moneycontrol

May 08, 2025
pulisher
May 06, 2025

Dr. Reddy’s Labs Q4 FY25 Results Preview: Revenue & PAT Outlook - Samco

May 06, 2025
pulisher
May 05, 2025

Validea's Top Health Care Stocks Based On Peter Lynch5/5/2025 - Nasdaq

May 05, 2025
pulisher
Apr 25, 2025

Asian ADRs See Mixed Results Despite Weekly Gains - Finimize

Apr 25, 2025
pulisher
Apr 25, 2025

Dr. Reddy’s Laboratories Ltd. ADR (RDY) Performance and Fundamentals Dashboard tells a completely different story - Sete News

Apr 25, 2025
pulisher
Apr 24, 2025

Dr. Reddy’s Looks Well Positioned for Long-Term Growth, Aided by Acquisitions and Partnerships - Morningstar

Apr 24, 2025
pulisher
Apr 23, 2025

Investing in Dr. Reddy’s Laboratories Ltd. ADR (RDY): What You Must Know - knoxdaily.com

Apr 23, 2025
pulisher
Apr 21, 2025

Dr Reddys Share Price Highlights: Dr. Reddys Stock Price History - The Economic Times

Apr 21, 2025
pulisher
Apr 17, 2025

NVO Stock Quote Price and Forecast - CNN

Apr 17, 2025
pulisher
Apr 16, 2025

Zacks Industry Outlook Dr. Reddy's, Sandoz And Teva Pharmaceuticals - Barchart.com

Apr 16, 2025
pulisher
Apr 16, 2025

Asian ADRs Climb, Showcasing North And South Asia Performances - Finimize

Apr 16, 2025
pulisher
Apr 14, 2025

PDD Holdings Stock Delivers Phenomenal 5.82% Surge to $95.77 on April 14 – Bullish Momentum Lifts Chinese Tech - Hindustan Herald

Apr 14, 2025
pulisher
Apr 14, 2025

3 Generic Drug Stocks To Watch Amid Trade War Jitters & Inflation Woes - Barchart.com

Apr 14, 2025
pulisher
Apr 14, 2025

Dr Reddy’s may cut workforce by 25%, including those in Rs 1 crore bracket: Report - financialexpress.com

Apr 14, 2025
pulisher
Apr 12, 2025

Asian ADRs Shine As Zai Lab And CNFinance Lead The Gains - Finimize

Apr 12, 2025
pulisher
Apr 12, 2025

Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by Massachusetts Financial Services Co. MA - MarketBeat

Apr 12, 2025
pulisher
Apr 11, 2025

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - TradingView

Apr 11, 2025
pulisher
Apr 11, 2025

Mixed Performance For Asian Stocks Traded On US Markets - Finimize

Apr 11, 2025
pulisher
Apr 11, 2025

Vanguard Group Inc. Purchases 3,911,404 Shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY) - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Asian Equities Traded in the US as American Depositary Receipts Tumble in Thursday Trading - TradingView

Apr 10, 2025
pulisher
Apr 10, 2025

TCS Q4 Results Highlights: Tata Group's IT giant reports slowest revenue growth in 4 years; US tariff hurt client deals - Mint

Apr 10, 2025
pulisher
Apr 09, 2025

US Tariffs on Pharma: Dr Reddy's to Sun Pharma—can Indian drugmakers escape Trump's tariff tantrums? - Mint

Apr 09, 2025
pulisher
Apr 08, 2025

Dr Reddy's Slapped Rs 2,395 Cr Income Tax Notice, Pharma Giant Denies Allegations - Medical Dialogues

Apr 08, 2025
pulisher
Apr 07, 2025

Asian Equities Traded in the US as American Depositary Receipts Sharply Lower in Monday Trading - TradingView

Apr 07, 2025
pulisher
Apr 07, 2025

Stocks to watch, April 7: IT, pharma, metals, oil-sensitive stocks, Nykaa, Dr Reddy's, Delhivery, Trent Ltd, and more - Upstox

Apr 07, 2025

Finanzdaten der Dr Reddys Laboratories Ltd Adr-Aktie (RDY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_specialty_generic HCM
$15.26
price down icon 0.26%
$124.61
price up icon 0.07%
$319.71
price down icon 1.31%
$8.46
price down icon 1.51%
$17.25
price down icon 1.54%
Kapitalisierung:     |  Volumen (24h):